Informatics in Radiology (infoRAD): Magnetic Resonance Imaging Workbench: analysis and visualization of dynamic contrast-enhanced MR imaging data.
暂无分享,去创建一个
John Suckling | Martin O Leach | David J Collins | Simon Walker-Samuel | James A d'Arcy | D. Collins | A. Padhani | M. Leach | S. Walker-Samuel | J. d’Arcy | J. Suckling | Anwar R Padhani
[1] A. Padhani,et al. A Phase I study of the angiogenesis inhibitor SU5416 (semaxanib) in solid tumours, incorporating dynamic contrast MR pharmacodynamic end points , 2005, British Journal of Cancer.
[2] M. Knopp,et al. The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations , 2005, British Journal of Cancer.
[3] D. Collins,et al. Dynamic magnetic resonance imaging of tumor perfusion , 2004, IEEE Engineering in Medicine and Biology Magazine.
[4] Martin A Lodge,et al. Combretastatin A4 phosphate has tumor antivascular activity in rat and man as demonstrated by dynamic magnetic resonance imaging. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] A. Padhani,et al. Reproducibility of dynamic contrast‐enhanced MRI in human muscle and tumours: comparison of quantitative and semi‐quantitative analysis , 2002, NMR in biomedicine.
[6] A. Padhani,et al. Assessing changes in tumour vascular function using dynamic contrast‐enhanced magnetic resonance imaging , 2002, NMR in biomedicine.
[7] A. Padhani,et al. Reproducibility of quantitative dynamic MRI of normal human tissues , 2002, NMR in biomedicine.
[8] J A d'Arcy,et al. Applications of sliding window reconstruction with cartesian sampling for dynamic contrast enhanced MRI , 2002, NMR in biomedicine.
[9] K Scheffler,et al. Analysis of input functions from different arterial branches with gamma variate functions and cluster analysis for quantitative blood volume measurements. , 2000, Magnetic resonance imaging.
[10] D P Dearnaley,et al. Dynamic contrast enhanced MRI of prostate cancer: correlation with morphology and tumour stage, histological grade and PSA. , 2000, Clinical radiology.
[11] P. Vaupel,et al. The Role of the Microcirculation in the Treatment of Malignant Tumors: Facts and Fiction , 2000 .
[12] N J Pelc,et al. Unaliasing by Fourier‐encoding the overlaps using the temporal dimension (UNFOLD), applied to cardiac imaging and fMRI , 1999, Magnetic resonance in medicine.
[13] J Sau,et al. A model of the dual effect of gadopentetate dimeglumine on dynamic brain MR images , 1999, Journal of magnetic resonance imaging : JMRI.
[14] J L Evelhoch,et al. Key factors in the acquisition of contrast kinetic data for oncology , 1999, Journal of magnetic resonance imaging : JMRI.
[15] M. Knopp,et al. Estimating kinetic parameters from dynamic contrast‐enhanced t1‐weighted MRI of a diffusable tracer: Standardized quantities and symbols , 1999, Journal of magnetic resonance imaging : JMRI.
[16] C. Kuhl,et al. Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions? , 1999, Radiology.
[17] D M Shames,et al. Quantification of the extraction fraction for gadopentetate across breast cancer capillaries , 1998, Magnetic resonance in medicine.
[18] N. Weidner,et al. Tumoural vascularity as a prognostic factor in cancer patients: the evidence continues to grow , 1998, The Journal of pathology.
[19] B. Rosen,et al. Contrast agents in functional MR imaging , 1997, Journal of magnetic resonance imaging : JMRI.
[20] J. Folkman. New perspectives in clinical oncology from angiogenesis research. , 1996, European journal of cancer.
[21] S. Fox,et al. Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation. , 1996, European journal of cancer.
[22] L. Norton,et al. Immunophenotype of intraductal carcinoma. , 1996, Archives of pathology & laboratory medicine.
[23] R. Gilles,et al. Ductal carcinoma in situ: MR imaging-histopathologic correlation. , 1995, Radiology.
[24] R. Kerbel,et al. Consequences of angiogenesis for tumor progression, metastasis and cancer therapy. , 1995, Anti-cancer drugs.
[25] M Recht,et al. Method for the quantitative assessment of contrast agent uptake in dynamic contrast‐enhanced MRI , 1994, Magnetic resonance in medicine.
[26] P. Tofts,et al. Measurement of the blood‐brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts , 1991, Magnetic resonance in medicine.
[27] H. Weinmann,et al. Pharmacokinetics of GdDTPA/dimeglumine after intravenous injection into healthy volunteers. , 1984, Physiological chemistry and physics and medical NMR.
[28] C. Starmer,et al. Indicator Transit Time Considered as a Gamma Variate , 1964, Circulation research.